Reply to Letter to the Editor for a Research Paper Entitled "Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention".

The article focuses on the prognostic significance of galectin-3 in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Topics include the association between high galectin-3 levels and heart failure development, rehospitalization, and adverse cardiovascular events in STEMI patients post-PCI, though it's not an independent predictor of cardiovascular mortality.